| Literature DB >> 30678053 |
Nicola Luigi Bragazzi1, Maha Sellami2, Iman Salem3, Rosalynn Conic4, Mark Kimak5, Paolo Daniele Maria Pigatto6, Giovanni Damiani7,8,9.
Abstract
Skin serves as the first protective line and barrier of the body. Like many other organs, skin can be affected by several disorders in response to external factors such as pathogens, ultraviolet light, and pollution, as well as endogenous alterations related to aging and/or oxidative stress disturbance. Researchers have reported new insights into how skin cells are altered in response to caloric restriction diets in mammals. One of the most well-known caloric restriction diets is the Ramadan intermittent fasting, which is a radical change in the diet plan of practitioners for the period of one lunar month. Ramadan fasting represents the fourth of the five pillars of the Islamic creed. Even though infirm individuals are waived to take part in this religious duty, patients with various health problems, including those with different skin disorders, might choose to share this event with peers and family members. No standardized protocols or guidelines exist, however, to advise their physicians on the proper management of their patients' condition during fasting. With an increasing Muslim population living in Western countries, this topic has started to draw substantial attention, not only of Middle-Eastern physicians, but also of clinicians in the West. For this purpose, we carried out a comprehensive overview on the topic. Our main findings are that: (1) there is a strong need for evidence-based suggestions and guidance. Literature on the impact of the Ramadan fasting, as well as of other kinds of fasting, on skin diseases is scarce and of poor quality, as well as the information available from the Internet; (2) patients willing to fast should be advised about the importance of taking proper treatments or consider alternative options including administration of trans-dermal/topical drugs, as they are permitted during daylight hours. Further, non-compliance has important, clinical and economic implications for an effective patient management.Entities:
Keywords: Ramadan or intermittent fasting; caloric restriction; chronotherapy and chronomedicine; compliance and adherence to treatment; skin disorders
Mesh:
Year: 2019 PMID: 30678053 PMCID: PMC6413166 DOI: 10.3390/nu11020249
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Factors affecting the skin. Abbreviations: UV (ultraviolet).
Figure 2The hypothesized mechanisms of the biphasic effect of intermittent fasting on wound healing. Abbreviations: IGFBP-1 (insulin-like growth factor binding protein 1); IGFBP-3 (insulin-like growth factor binding protein 3); P5C (pyrroline-5-carboxylate); PEP (phosphoenolpyruvate); PIF (prolidase inhibitor factor); PK (pyruvate kinase); TNF-α (tumor necrosis factor alpha); VEGF (vascular endothelial growth factor).
Figure 3The anti-aging effect of fasting. Abbreviations: CML (carboxymethyl lysine).
Figure 4The major effects of fasting on skin anatomy, homeostasis dynamics and physiology. Abbreviations: CML (carboxymethyl lysine); HSCs (hematopoietic stem cells); IGF-1 (insulin-like growth factor 1); NKs (natural killers); P5C (pyrroline-5-carboxylate); SCs (stem cells); VEGF (vascular endothelial growth factor).
Summary of animal models and experiments showing different effects of various fasting models on skin homeostasis dynamics.
| Animal Model | Fasting Regimen | Results | Explanation | References |
|---|---|---|---|---|
| Swiss Mice | Long term caloric restriction to 60% for 6 months | Maintained/preserved thermal homeostasis | Maintenance of fur due to increase of HFSC pool | Forni et al., 2017 [ |
| Hairless Mice | Caloric restriction | Compromised | Decreased synthesis of epidermal cholesterol | Wu-Pong et al., 1994 [ |
| UM-HET3 Mice | Caloric restriction to 70% for 3–18 months | Decreased retinoid-induced skin irritation without interfering with treatment efficacy | Increased local antioxidant levels | Varani et al., 2008 [ |
| Suri Mice | Short-term fast for 4 day/2weeks for 2 months | Enhancement of wound healing | Increased MQ production and release of TNF-α and VEGF | Hayati et al., 2011 [ |
| Fisher-344 Rats | 40% calorie restricted diet begun 48 hours before wounding and continued during healing | Delayed wound healing | Decreased collagen synthesis | Hunt et al., 2012 [ |
| Rats | One time 72-hour fast with access to water only | Delayed wound healing | Decreased level of the proline precursor, P5C, resulting in suppression of IGF-1 dependent stimulation of collagen synthesis | Miltyk and Palka, 2000 [ |
| Rats | One time 72-hour fast with access to water only | Delayed wound healing | Decreased availability of IGF-1 due to up-regulation of IGFBP-1 that has high affinity to IGF-1 | Cechowska-Pasko et al., 2003 [ |
| Rats | One time 72-hour fast with access to water only | Delayed wound healing | Decreased prolidase activity leading to decreased proline salvage and reduction of collagen synthesis | Cechowska-Pasko et al., 2004 [ |
| Mice | 2-day water-only fast before chemotherapy | Protective effect against toxic effects of chemotherapy on HSCs | Decreased levels of IGF-1 and PKA, resulting in modulation of HSC, promoting self-renewal, lineage regeneration and proliferation | Cheng et al., 2014 [ |
| SENCAR Mice | 20% calorie restricted diet for 5 days/week for 10 weeks | Anti-carcinogenic role | Decrease in mitogenesis downstream signaling cascade of IGF-1 (PI3K-AKT and Ras-MAPK) | Xie et al., 2007 [ |
| Rodent | Long term 60% caloric restriction | Decreased aging | Decreased concentration of glycoxidation products (CML and pentosidine) in cutaneous collagen | Cefalu et al., 1995 [ |
Abbreviations: CML (carboxymethyl lysine); HFSC (hair follicle stem cells); HSC (hematopoietic stem cells); IGF-1: insulin-like growth factor 1; IGFBP-1 (insulin-like growth factor binding protein 1); MAPK (mitogen activated protein kinase); MMP (matrix metalloproteinase); MQ (macrophages); P5C (pyrroline-5-carboxylate); PI3K-AKT (phosphoinositide3-kinase-protein kinase B); PKA (protein kinase A); TNF-α (tumor necrosis factor alpha); VEGF (vascular endothelial growth factor).